4//SEC Filing
Fridriksdottir Hafrun 4
Accession 0001209191-21-051075
CIK 0000818686other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:04 PM ET
Size
5.3 KB
Accession
0001209191-21-051075
Insider Transaction Report
Form 4
Fridriksdottir Hafrun
Executive VP, Global R&D
Transactions
- Sale
Ordinary Shares
2021-08-10$9.95/sh−50,860$506,021→ 41,411.514 total
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.91 to $10.00, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001561458
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:04 PM ET
- Size
- 5.3 KB